Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtech firms demand more say in EU human tissue debate

This article was originally published in Clinica

Executive Summary

Calls for the European Commission to set up a tissue engineering regulatory body have led to fears among the medical device industry that the pharmaceutical sector could gain too much regulatory control. Proposals concerning the regulatory oversight of human tissue products just published by the European Commission's Scientific Committee on Medicinal Products and Medical Devices (SCMPMD)* have prompted the concerns with companies seeing oversight slipping towards the European Medicines Evaluation Agency.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts